Med–Lysosomal 2020 brings together international leaders in the field of Lysosomal Diseases to share their knowledge from the basic mechanisms underlying these Lysosomal Diseases to the present and future therapies.
The conference focuses on the diagnosis and treatment as well as new therapeutic modalities already in advanced stages of development of four main Lysosomal Diseases: Gaucher, Fabry, Pompe and various Lysosomal Diseases, focusing mainly but not exclusively on MPSs.
If you are unable to attend Med–Lysosomal 2020, you can still drop by our virtual booth!
CENTOGENE ON-DEMAND SESSION
Join Prof Arndt Rolfs, MD, CENTOGENE CEO as he shares his expertise on why biomarkers are essential for an early and reliable diagnosis in rare metabolic diseases.
Presentation accessibility: 1 June – 31 July, 2020
Please note that attending the Med–Lysosomal 2020 requires registration.